Clinical Trial Update: New Analytic Tools for aHUS and C3G Diagnosis [NA]

View source ↗

Summary

An active-not-recruiting trial from Mario Negri Institute is evaluating new analytic tools to improve the diagnosis of atypical hemolytic uremic syndrome and C3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome
• C3 Glomerulopathy
• Membranoproliferative Glomerulonephritis

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis | NA | Status: ACTIVE_NOT_RECRUITING